Optiscan Imaging Limited announce that it has entered into a collaboration through a know-how agreement with Mayo Clinic to develop a digital confocal laser endomicroscopic imaging system for use in robotic surgery. The collaboration combines Optiscan?s engineering expertise in digital endomicroscopic hardware and software development with Mayo Clinic?s know-how in robotic surgery and quality patient care. The agreement, which covers a 24-month co-development plan, will bring together experts from both companies to develop a robot-compatible endomicroscopic imaging system with an initial focus on robotic-assisted breast cancer surgery.

Mayo Clinic is the largest integrated, not-for-profit medical group practice in the world, focussed on transforming health care and building a healthier world. Its drive to deliver better medical care has earned it more top rankings for high-quality patient care than any other health care organization. It has more #1 rankings than any other hospital in the US, and is top-ranked in more specialties than any other US hospital.

The hospital undertakes more than 141,000 surgical cases and performs more than 4,000 robotic surgery cases a year. The robotic-assisted surgery market is experiencing significant growth and is expected to continue expanding driven by technological advancements, increasing adoption, rising prevalence of chronic diseases, an aging population, surgeon demand, and favourable reimbursement policies. The US robotic surgery service market was valued at $1.8 billion in 2022 and is estimated to grow at a compound annual growth rate (CAGR) of 17.3% to reach $6.4 billion in 2030.